Revolution Medicines (RVMD) Revenue (2019 - 2023)

Revolution Medicines has reported Revenue for 5 years, with the latest figure at $742000.0 in Q4 2023.

• For the quarter ending Q4 2023, Revenue fell 95.16% year-over-year to $742000.0; the trailing twelve-month figure through Sep 2024 stood at $742000.0 (down 97.16% YoY), and the FY2023 full-year result was $11.6 million, down 67.27% from the prior year.
• Revenue for Q4 2023 stood at $742000.0, down from $3.8 million in the prior quarter.
• The five-year high for Revenue was $15.3 million in Q4 2022, with the low at $742000.0 in Q4 2023.
• Average Revenue over 5 years is $8.9 million, with a median of $9.5 million recorded in 2021.
• Year-over-year, Revenue surged 204.81% in 2022 and plunged 95.16% in 2023.
• Tracing RVMD's Revenue over 5 years: stood at $12.1 million in 2019, then decreased by 27.61% to $8.8 million in 2020, then climbed by 8.1% to $9.5 million in 2021, then jumped by 62.05% to $15.3 million in 2022, then sank by 95.16% to $742000.0 in 2023.
• The last three Revenue figures came in at $742000.0 (Q4 2023), $3.8 million (Q2 2023), and $7.0 million (Q1 2023), per Business Quant data.

Peer Comparison